The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments.
 
Philip Emmerich
No Relationships to Disclose
 
Kristina A. Matkowskyj
No Relationships to Disclose
 
Stephanie McGregor
No Relationships to Disclose
 
Sean Kraus
No Relationships to Disclose
 
Kristen Bischel
No Relationships to Disclose
 
Tonela Qyli
No Relationships to Disclose
 
Darya Buehler
No Relationships to Disclose
 
Cheri Pasch
No Relationships to Disclose
 
Christopher Babiarz
No Relationships to Disclose
 
Mitchell Depke
No Relationships to Disclose
 
Linda Clipson
No Relationships to Disclose
 
Kari Braun Wisinski
Consulting or Advisory Role - AstraZeneca; Genomic Health
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer; Pfizer; Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health
 
Mark E. Burkard
Consulting or Advisory Role - Novartis; Pointcare genomics; Strata Oncology
Research Funding - Abbvie (Inst); Loxo (Inst); Merck (Inst); Puma Biotechnology (Inst); Strata Oncology (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent for a method to detect recombination events with CRISPR-mediated editing.; I have patent for implantable/localized drug delivery device that can sample the tumor microenvironment and deliver drug.
 
Andrew Baschnagel
No Relationships to Disclose
 
Nataliya Volodymyrivna Uboha
Consulting or Advisory Role - AstraZeneca; EMD Serono; Flatiron Health; Gerson Lehrman Group; Incyte; ipsen; LEK; Lilly; Lilly; M3; Taiho Pharmaceutical
Research Funding - EMD Serono (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
 
Fotis Asimakopoulos
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Acrotech Biopharma; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech/Roche; Novocure; Promega; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Revolution Medicines (Inst)